May 06, 2026

Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis

Caris MI Clarity leverages AI to transform how recurrence risk is understood and applied in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer IRVING, Texas, May 5, 2026 /PRNewswire/ -- Caris Life Sciences®...

recent articles

Computational pathology is a widely used term nowadays, but its exact meaning is often subject to interpretation. For us at Ibex Medical Analytics, it’s all about the smart use of algorithms and computing power to better diagnose diseases,...

New Software Application Quantifies Changes in Dendritic Spine Morphology Over Time Williston, VT — The ability to track the changes that occur in dendritic spine morphology over time is critical to many scientific studies, which is why...

REGISTER NOW How do you decipher information from complex imaging technologies? Hyperplexing technologies have drastically increased the number of biomarkers that can be analyzed in tissue sections, but finding meaningful differences...

3DHISTECH UPGRADES PANNORAMIC® MIDI II, ITS BEST-SELLING SLIDE SCANNER FOR DIGITAL PATHOLOGY PANNORAMIC® MIDI II, 3DHISTECH’s best-selling member of the PANNORAMIC® scanner range is an award-winning all-round digital slide scanner...

OR

platinum partners

gold partners

Silver Partners

Media Partners